Integrated Filing — IndAS



General information about company

Scrip Code 544222
NSE Symbol AKUMS
MSEI Symbol NOTLISTED
ISIN INE09XN01023
Name of company Akums Drugs and Pharmaceuticals Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 02-11-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 28-10-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Pharmaceuticals
Start date and time of board meeting 02-11-2026   14:33:00
End date and time of board meeting 02-11-2026   16:23:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 13-11-2025
Indicate Company website link for updated RPT policy of the Company https://www.akums.in/wp-content/uploads/2025/11/Related-Party-Transaction-Policy.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
There is no default on loan and debt securities during the quater ended on 30.09.2026.



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 39,504.70 78,732.20
Other income 2,579.70 5,190.10
Total income 42,084.40 83,922.30
2 Expenses
(a) Cost of materials consumed 24,564.20 49,920.40
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (328.90) (2,018.50)
(d) Employee benefit expense 6,515.70 12,407.50
(e) Finance costs 300.30 547.90
(f) Depreciation, depletion and amortisation expense 1,351.30 2,630.80
(f) Other Expenses
1 Other Expenses 5,297.00 10,115.80
Total other expenses 5,297.00 10,115.80
Total expenses 37,699.60 73,603.90
3 Total profit before exceptional items and tax 4,384.80 10,318.40
4 Exceptional items 0.00 0.00
5 Total profit before tax 4,384.80 10,318.40
6 Tax expense
7 Current tax 1,177.70 2,712.70
8 Deferred tax (56.60) (141.90)
9 Total tax expenses 1,121.10 2,570.80
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 3,263.70 7,747.60
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 3,263.70 7,747.60
17 Other comprehensive income net of taxes (133.30) (27.90)
18 Total Comprehensive Income for the period 3,130.40 7,719.70
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 3,062.10 3,062.10
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 2.13 5.06
Diluted earnings (loss) per share from continuing operations 2.13 5.06
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 2.13 5.06
Diluted earnings (loss) per share from continuing and discontinued operations 2.13 5.06
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) For detailed notes, please refer the unaudited financial results uploaded on stock exchanges in pdf format on 02.11.2026



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 40,958.20
Capital work-in-progress 8,094.20
Investment property 1,790.80
Goodwill 0.00
Other intangible assets 503.90
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 36,730.30
Trade receivables, non-current 0.00
Loans, non-current 70,343.40
Other non-current financial assets
1 Others financial assets 1,085.00
Total of other non-current financial assets 1,085.00
Total non-current financial assets 1,08,158.70
Deferred tax assets (net)
Other non-current assets
1 Other non-current assets 1,268.00
2 Non-current tax assets (net) 748.70
Total of other non-current assets 2,016.70
Total non-current assets 1,61,522.50
2 Current assets
Inventories 27,160.80
Current financial asset
Current investments 0.00
Trade receivables, current 21,869.50
Cash and cash equivalents 3,962.70
Bank balance other than cash and cash equivalents 64,232.10
Loans, current 0.00
Other current financial assets
Total of other current financial assets 345.10
Total current financial assets 90,409.40
Current tax assets (net)
Other current assets
1 Other current assets 11,486.50
Total of other current assets 11,486.50
Total current assets 1,29,056.70
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 2,90,579.20
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 3,062.10
Other equity 2,42,821.20
Total equity attributable to owners of parent 2,45,883.30
Non controlling interest
Total equity 2,45,883.30
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Other non-current financial liabilities 1,607.20
2 Lease liabilities 4,300.30
Total of other non-current financial liabilities 5,907.50
Total non-current financial liabilities 5,907.50
Provisions, non-current 1,832.30
Deferred tax liabilities (net) 643.10
Deferred government grants, Non-current 0.00
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 8,382.90
Current liabilities
Current financial liabilities
Borrowings, current 0.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 3,471.80
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 21,579.90
Total Trade payable 25,051.70
Other current financial liabilities
1 Other current financial liabilities 7,652.20
2 Lease liabilities 181.20
Total of other current financial liabilities 7,833.40
Total current financial liabilities 32,885.10
Other current liabilities 1,495.70
1 Other current liabilities 1,495.70
Total of other current liabilities 1,495.70
Provisions, current 930.30
Current tax liabilities (Net) 1,001.90
Deferred government grants, Current 0.00
Total current liabilities 36,313.00
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 44,695.90
Total equity and liabilites 2,90,579.20
Disclosure of notes on assets and liabilities Textual Information(1)



Text Block

Textual Information(1) Property Plant and equipment includes Right-of-use assets of INR 701.12 million.



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Re-measurement gains/(losses) on defined benefit plans (178.20) (37.30)
Total Amount of items that will not be reclassified to profit and loss (178.20) (37.30)
2 Income tax relating to items that will not be reclassified to profit or loss (44.90) (9.40)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income (133.30) (27.90)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 10,318.40
Adjustments for reconcile profit (loss)
Adjustments for finance costs 547.90
Adjustments for decrease (increase) in inventories (4,168.20)
Adjustments for decrease (increase) in trade receivables, current 108.00
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (3,383.80)
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 473.30
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 4,903.80
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 2,630.80
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 288.90
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 1,279.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 16.00
Adjustments for dividend income 0.00
Adjustments for interest income 0.00
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow (175.90)
Other adjustments to reconcile profit (loss) 20.30
Other adjustments for non-cash items (223.30)
Share of profit and loss from partnership firm or association of persons or limited liability partnerships (197.70)
Total adjustments for reconcile profit (loss) 2,119.10
Net cash flows from (used in) operations 12,437.50
Dividends received 0.00
Interest paid 0.00
Interest received (4,693.50)
Income taxes paid (refund) 1,948.90
Other inflows (outflows) of cash 125.80
Net cash flows from (used in) operating activities 5,920.90
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 128.60
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 1,731.60
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 72.30
Purchase of property, plant and equipment 5,284.40
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets (6,671.00)
Cash advances and loans made to other parties 52,487.00
Cash receipts from repayment of advances and loans made to other parties 43,085.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 6,147.90
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 175.90
Net cash flows from (used in) investing activities (16.30)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 1,355.20
Payments of lease liabilities 288.70
Dividends paid 4,592.50
Interest paid 343.90
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (6,580.30)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (675.70)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (675.70)
Cash and cash equivalents cash flow statement at beginning of period 4,638.40
Cash and cash equivalents cash flow statement at end of period 3,962.70





Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Any other transaction Loan given Exempted under regulation 23(5) 3,401.00 33,068.00 34,353.00 Loan 7.2500 Upto March-2031 Unsecured Business purpose
2 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Any other transaction Loan repaid Exempted under regulation 23(5) 2,116.00 0.00 0.00
3 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Any other transaction Interest income Exempted under regulation 23(5) 1,226.10 180.80 184.20
4 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company Exempted under regulation 23(5) 1.90 0.00 0.00
5 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Sale of goods or services Exempted under regulation 23(5) 17.40 13.50 7.40
6 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Any other transaction Sale of Property, Plant and Equipment Exempted under regulation 23(5) 21.40 0.00 0.00
7 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Any other transaction Guarantee Comission Income Exempted under regulation 23(5) 2.50 0.00 0.00
8 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Purchase of goods or services Exempted under regulation 23(5) 35.00 15.60 0.20
9 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Any other transaction Expenses incurred Exempted under regulation 23(5) 5.90 0.00 0.00
10 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Any other transaction Purchase of Property, Plant and Equipment Exempted under regulation 23(5) 170.00 0.00 0.00
11 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Any other transaction Loan given Exempted under regulation 23(5) 18,698.00 16,290.00 19,245.00 Loan 7.2500 Upto March-2031 Unsecured Business purpose
12 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Any other transaction Loan repaid Exempted under regulation 23(5) 15,743.00 0.00 0.00
13 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Any other transaction Interest income Exempted under regulation 23(5) 736.40 88.40 108.90
14 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company Exempted under regulation 23(5) 32.70 0.00 0.00
15 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Any other transaction Rent Received Exempted under regulation 23(5) 93.10 0.00 0.00
16 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Sale of goods or services Exempted under regulation 23(5) 270.30 158.50 68.70
17 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Any other transaction Expenses incurred Exempted under regulation 23(5) 0.40 0.00 0.00
18 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Any other transaction Job Work Charges Exempted under regulation 23(5) 331.30 0.00 0.00
19 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Purchase of goods or services Exempted under regulation 23(5) 1,243.40 223.40 302.20
20 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Any other transaction Purchase of Property, Plant and Equipment Exempted under regulation 23(5) 0.20 0.00 0.00
21 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Any other transaction Sale of Property, Plant and Equipment Exempted under regulation 23(5) 0.30 0.00 0.00
22 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Any other transaction Loan given Exempted under regulation 23(5) 5,843.00 0.00 600.00 Loan 7.2500 Upto March-2031 Unsecured Business purpose
23 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Any other transaction Loan repaid Exempted under regulation 23(5) 5,243.00 0.00 0.00
24 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Any other transaction Interest income Exempted under regulation 23(5) 6.40 2.60 3.00
25 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company Exempted under regulation 23(5) 20.60 0.00 0.00
26 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Any other transaction Rent Received Exempted under regulation 23(5) 28.30 0.00 0.00
27 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Any other transaction Expenses incurred Exempted under regulation 23(5) 0.00 0.00 0.00
28 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Any other transaction Sales of RODTEP scrips Exempted under regulation 23(5) 2.00 0.00 0.00
29 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Sale of goods or services Exempted under regulation 23(5) 64.40 18.80 15.00
30 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Purchase of goods or services Exempted under regulation 23(5) 3,392.20 1,694.70 659.30
31 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Any other transaction Purchase of Property, Plant and Equipment Exempted under regulation 23(5) 0.10 0.00 0.00
32 Akums Drugs and Pharmaceuticals Ltd. Nicholas Healthcare Ltd. Wholly owned subsidiary Sale of goods or services Exempted under regulation 23(5) 175.50 163.40 164.20
33 Akums Drugs and Pharmaceuticals Ltd. Nicholas Healthcare Ltd. Wholly owned subsidiary Any other transaction Service Income Exempted under regulation 23(5) 1.80 0.00 0.00
34 Akums Drugs and Pharmaceuticals Ltd. Nicholas Healthcare Ltd. Wholly owned subsidiary Any other transaction Guarantee Comission Income Exempted under regulation 23(5) 5.40 0.00 0.00
35 Akums Drugs and Pharmaceuticals Ltd. Nicholas Healthcare Ltd. Wholly owned subsidiary Any other transaction Corporate guarantee withdrawn Exempted under regulation 23(5) 500.00 0.00 0.00
36 Akums Drugs and Pharmaceuticals Ltd. Nicholas Healthcare Ltd. Wholly owned subsidiary Any other transaction Rent Received Exempted under regulation 23(5) 0.00 0.00 0.00
37 Akums Drugs and Pharmaceuticals Ltd. Nicholas Healthcare Ltd. Wholly owned subsidiary Any other transaction Expenses incurred Exempted under regulation 23(5) 0.00 0.00 0.00
38 Akums Drugs and Pharmaceuticals Ltd. Nicholas Healthcare Ltd. Wholly owned subsidiary Any other transaction Purchase of Property, Plant and Equipment Exempted under regulation 23(5) 0.50 0.00 0.00
39 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Any other transaction Loan given Exempted under regulation 23(5) 700.00 0.00 700.00 Loan 7.2500 Upto Dec-2026 Unsecured Business purpose
40 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Any other transaction Interest income Exempted under regulation 23(5) 10.10 0.00 9.10
41 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company Exempted under regulation 23(5) 0.60 0.00 0.00
42 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Any other transaction Expenses incurred Exempted under regulation 23(5) 0.20 0.00 0.00
43 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Any other transaction Guarantee Comission Income Exempted under regulation 23(5) 1.50 0.00 0.00
44 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Sale of goods or services Exempted under regulation 23(5) 220.20 339.70 211.70
45 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Any other transaction Service Income Exempted under regulation 23(5) 1.90 0.00 0.00
46 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Any other transaction Corporate guarantee withdrawn Exempted under regulation 23(5) 500.00 0.00 0.00
47 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Purchase of goods or services Exempted under regulation 23(5) 0.00 0.90 0.00
48 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Any other transaction Purchase of Property, Plant and Equipment Exempted under regulation 23(5) 10.30 0.00 0.00
49 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Loan given Exempted under regulation 23(5) 21,574.00 3,450.00 5,145.00 Loan 7.2500 Upto March-2031 Unsecured Business purpose
50 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Loan repaid Exempted under regulation 23(5) 19,879.00 0.00 0.00
51 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Interest income Exempted under regulation 23(5) 115.30 1.90 23.60
52 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company Exempted under regulation 23(5) 64.00 0.00 0.00
53 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Rent Received Exempted under regulation 23(5) 54.50 0.00 0.00
54 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Sale of goods or services Exempted under regulation 23(5) 2,022.60 520.00 717.50
55 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Sale of Property, Plant and Equipment Exempted under regulation 23(5) 7.40 0.00 0.00
56 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Service Income Exempted under regulation 23(5) 230.00 0.00 0.00
57 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Expenses paid by other Group Company Exempted under regulation 23(5) 1.50 0.00 0.00
58 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Job Work Charges Exempted under regulation 23(5) 937.30 0.00 0.00
59 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Purchase of goods or services Exempted under regulation 23(5) 1,695.40 1,393.50 1,179.70
60 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Purchase of Property, Plant and Equipment Exempted under regulation 23(5) 25.60 0.00 0.00
61 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Job Work Income Exempted under regulation 23(5) 105.60 0.00 0.00
62 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Expenses incurred Exempted under regulation 23(5) 12.70 0.00 0.00
63 Akums Drugs and Pharmaceuticals Ltd. Unosource Pharma Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company Exempted under regulation 23(5) 4.30 0.00 0.00
64 Akums Drugs and Pharmaceuticals Ltd. Unosource Pharma Ltd. Wholly owned subsidiary Any other transaction Guarantee Comission Income Exempted under regulation 23(5) 10.00 0.00 0.00
65 Akums Drugs and Pharmaceuticals Ltd. Unosource Pharma Ltd. Wholly owned subsidiary Purchase of goods or services Exempted under regulation 23(5) 0.00 0.60 0.00
66 Akums Drugs and Pharmaceuticals Ltd. Unosource Pharma Ltd. Wholly owned subsidiary Sale of goods or services Exempted under regulation 23(5) 4,343.00 3,093.50 3,003.50
67 Akums Drugs and Pharmaceuticals Ltd. Unosource Pharma Ltd. Wholly owned subsidiary Any other transaction Service Income Exempted under regulation 23(5) 3.00 0.00 0.00
68 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP wholly owned subsidiary Any other transaction Loan given Exempted under regulation 23(5) 1,734.00 1,389.00 3,123.00 Loan 7.2500 Upto March-2031 Unsecured Business purpose
69 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP wholly owned subsidiary Any other transaction Interest income Exempted under regulation 23(5) 82.90 61.60 96.90
70 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP wholly owned subsidiary Any other transaction Expense incurred on behalf of Company Exempted under regulation 23(5) 1.20 0.00 0.00
71 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP wholly owned subsidiary Any other transaction Expenses incurred Exempted under regulation 23(5) 21.80 0.00 0.00
72 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP wholly owned subsidiary Sale of goods or services Exempted under regulation 23(5) 40.50 16.70 68.60
73 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP wholly owned subsidiary Any other transaction Sale of Property, Plant and Equipment Exempted under regulation 23(5) 16.80 0.00 0.00
74 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP wholly owned subsidiary Any other transaction Consumption of stores and spare parts Exempted under regulation 23(5) 478.80 0.00 0.00
75 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP wholly owned subsidiary Sale of goods or services Exempted under regulation 23(5) 264.30 50.40 123.90
76 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP wholly owned subsidiary Any other transaction Purchase of Property, Plant and Equipment Exempted under regulation 23(5) 47.40 0.00 0.00
77 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP wholly owned subsidiary Any other transaction Repairs and maintenance- Plant and machinery Exempted under regulation 23(5) 85.80 0.00 0.00
78 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP wholly owned subsidiary Any other transaction Job Work Charges Exempted under regulation 23(5) 8.80 0.00 0.00
79 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP wholly owned subsidiary Any other transaction Share of profit from Partnership firm/ LLP Exempted under regulation 23(5) 197.70 1,731.60 197.70
80 Akums Drugs and Pharmaceuticals Ltd. May and Baker Pharmaceuticals Ltd. Entity in which KMP/ relatives of KMP are interested Sale of goods or services 600.00 Approved 10.00 2.50 3.90
81 Akums Drugs and Pharmaceuticals Ltd. Medibox Pharma Pvt. Ltd. Wholly owned subsidiary Sale of goods or services Exempt under regulation 23(5) 3.30 7.70 2.40
82 Akums Drugs and Pharmaceuticals Ltd. Medibox Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company Exempt under regulation 23(5) 1.20 0.00 0.00
83 Akums Drugs and Pharmaceuticals Ltd. Medibox Pharma Pvt. Ltd. wholly owned subsidiary Any other transaction Guarantee Comission Income Exempt under regulation 23(5) 4.30 0.00 0.00
84 Akums Drugs and Pharmaceuticals Ltd. Medibox Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Service Income Exempt under regulation 23(5) 1.80 0.00 0.00
85 Akums Drugs and Pharmaceuticals Ltd. Medibox Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Expenses incurred Exempt under regulation 23(5) 2.10 0.00 0.00
86 Akums Drugs and Pharmaceuticals Ltd. Medibox Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Corporate guarantee withdrawn Exempt under regulation 23(5) 200.00 0.00 0.00
87 Akums Drugs and Pharmaceuticals Ltd. Medibox Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Purchase of Property, Plant and Equipment Exempt under regulation 23(5) 8.10 0.00 0.00
88 Akums Drugs and Pharmaceuticals Ltd. Medibox Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Security deposit repaid Exempt under regulation 23(5) 26.80 26.80 0.00
89 Akums Drugs and Pharmaceuticals Ltd. Akumentis Healthcare Limited Subsidiary Sale of goods or services 4,000.00 Approved 1,218.50 393.50 94.20
90 Akums Drugs and Pharmaceuticals Ltd. Akumentis Healthcare Limited Subsidiary Any other transaction Service Income 100.00 Approved 1.80 0.00 0.00
91 Akums Drugs and Pharmaceuticals Ltd. Qualymed Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Loan given Exempt under regulation 23(5) 537.00 6,217.10 6,649.10 Loan 7.2500 Upto May-2028 Unsecured Business purpose
92 Akums Drugs and Pharmaceuticals Ltd. Qualymed Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Loan repaid Exempt under regulation 23(5) 105.00 0.00 0.00
93 Akums Drugs and Pharmaceuticals Ltd. Qualymed Pharma Pvt. Ltd. Wholly owned subsidiary Sale of goods or services Exempt under regulation 23(5) 0.20 3.10 0.00
94 Akums Drugs and Pharmaceuticals Ltd. Qualymed Pharma Pvt. Ltd. Wholly owned subsidiary Purchase of goods or services Exempt under regulation 23(5) 69.10 18.10 23.40
95 Akums Drugs and Pharmaceuticals Ltd. Qualymed Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company Exempt under regulation 23(5) 0.60 0.00 0.00
96 Akums Drugs and Pharmaceuticals Ltd. Qualymed Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Interest income Exempt under regulation 23(5) 233.30 34.40 35.50
97 Akums Drugs and Pharmaceuticals Ltd. Qualymed Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Rent Paid Exempt under regulation 23(5) 18.30 0.00 0.00
98 Akums Drugs and Pharmaceuticals Ltd. Qualymed Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Expenses paid by other Group Company Exempt under regulation 23(5) 22.20 0.00 0.00
99 Akums Drugs and Pharmaceuticals Ltd. Akums Health and Education Society Entity in which KMP/ relatives of KMP are interested Sale of goods or services 200.00 Approved 0.10 0.00 0.10
100 Akums Drugs and Pharmaceuticals Ltd. Akums Health and Education Society Entity in which KMP/ relatives of KMP are interested Any other transaction CSR Contribution 300.00 Approved 84.40 0.00 0.00
101 Akums Drugs and Pharmaceuticals Ltd. Akums Foundation Entity in which KMP/ relatives of KMP are interested Sale of goods or services 200.00 Approved 0.20 0.00 0.20
102 Akums Drugs and Pharmaceuticals Ltd. Akums Foundation Entity in which KMP/ relatives of KMP are interested Any other transaction CSR Contribution 300.00 Approved 84.40 0.00 0.00
103 Akums Drugs and Pharmaceuticals Ltd. Akome Lifecare Pvt. Ltd. Entity in which KMP/ relatives of KMP are interested Any other transaction Rent Paid 400.00 Approved 119.20 0.00 0.00
104 Akums Drugs and Pharmaceuticals Ltd. Akome Lifecare Pvt. Ltd. Entity in which KMP/ relatives of KMP are interested Any other transaction Expense incurred on behalf of Company 25.00 Approved 0.40 0.00 0.00
105 Akums Drugs and Pharmaceuticals Ltd. Akome Lifecare Pvt. Ltd. Entity in which KMP/ relatives of KMP are interested Purchase of goods or services 500.00 Approved 231.10 19.40 46.60
106 Akums Drugs and Pharmaceuticals Ltd. Akome Lifecare Pvt. Ltd. Entity in which KMP/ relatives of KMP are interested Sale of goods or services 50.00 Approved 0.00 0.90 0.00
107 Akums Drugs and Pharmaceuticals Ltd. Akome Lifecare Pvt. Ltd. Entity in which KMP/ relatives of KMP are interested Any other transaction Expenses paid by other Group Company 400.00 Approved 30.40 0.00 0.00
108 Akums Drugs and Pharmaceuticals Ltd. Akums Employee Benefit Trust Employee Benefit Trust Any other transaction Loan repaid 0.00 Approved 75.00 30,044.00 29,969.00 Loan 0 As per agreed terms Unsecured For acquisition of shares under ESOP scheme
109 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare UK Ltd Wholly owned subsidiary Any other transaction Loan given Exempt under regulation 23(5) 0.00 62.80 63.60 Loan 7.2500 Upto Dec-2030 Unsecured Business purpose
110 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare UK Ltd Wholly owned subsidiary Any other transaction Interest income Exempt under regulation 23(5) 2.20 1.20 3.40
111 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare UK Ltd Wholly owned subsidiary Any other transaction Investment through acquisition of shares Exempt under regulation 23(5) 128.10 0.00 0.00
112 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare (Zambia) Pvt Ltd Subsidiary Any other transaction Investment through acquisition of shares 0.50 Approved 0.50 0.00 0.00
113 Akums Drugs and Pharmaceuticals Ltd. Mr. Sanjeev Jain Managing Director Any other transaction Director remuneration 1,200.00 Approved 470.80 137.00 165.00
114 Akums Drugs and Pharmaceuticals Ltd. Mr. Sanjeev Jain Managing Director Any other transaction Refund of excess IPO expenses Approved 0.00 67.90 0.00
115 Akums Drugs and Pharmaceuticals Ltd. Mr. Sanjeev Jain Managing Director Any other transaction Rent Paid 7.10 Approved 1.40 0.00 0.00
116 Akums Drugs and Pharmaceuticals Ltd. Mr. Sandeep Jain Managing Director Any other transaction Director remuneration 1,200.00 Approved 470.80 137.00 165.00
117 Akums Drugs and Pharmaceuticals Ltd. Mr. Sandeep Jain Managing Director Any other transaction Refund of excess IPO expenses Approved 0.00 67.90 0.00
118 Akums Drugs and Pharmaceuticals Ltd. Mr. Sandeep Jain Managing Director Any other transaction Rent Paid 18.80 Approved 9.60 0.00 0.00
119 Akums Drugs and Pharmaceuticals Ltd. Ms. Arushi Jain Relatives of KMP Remuneration 62.90 Approved 34.80 5.00 5.40
120 Akums Drugs and Pharmaceuticals Ltd. Mr. Umang Jain Relatives of KMP Remuneration 24.80 Approved 18.90 2.20 2.50
121 Akums Drugs and Pharmaceuticals Ltd. Ms. Shivangi Jain Relatives of KMP Remuneration 24.80 Approved 18.90 2.20 2.50
122 Akumentis Healthcare Limited Akums Healthcare Ltd. Fellow subsidiary Purchase of goods or services 10,000.00 Approved 110.50 65.80 114.70
123 Akumentis Healthcare Limited Malik Lifesciences Pvt. Ltd. Fellow subsidiary Purchase of goods or services 1,500.00 Approved 192.40 25.10 51.90
124 Akumentis Healthcare Limited Maxcure Nutravedics Ltd. Fellow subsidiary Purchase of goods or services 1,500.00 Approved 140.10 47.80 43.40
125 Akumentis Healthcare Limited Nicholas Healthcare Ltd. Fellow subsidiary Any other transaction Loan given 2,500.00 Approved 0.00 375.00 375.00 Loan 7.2500 Upto Jan-2028 Unsecured Business purpose
126 Akumentis Healthcare Limited Nicholas Healthcare Ltd. Fellow subsidiary Any other transaction Interest income 388.30 Approved 13.60 2.10 4.10
127 Akumentis Healthcare Limited Plenteous Pharmaceuticals Ltd. Fellow subsidiary Any other transaction Loan given 2,500.00 Approved 0.00 4,079.30 4,079.30 Loan 7.2500 Upto Jan-2028 Unsecured Business purpose
128 Akumentis Healthcare Limited Plenteous Pharmaceuticals Ltd. Fellow subsidiary Any other transaction Interest income 399.50 Approved 148.30 0.00 87.40
129 Akumentis Healthcare Limited Plenteous Pharmaceuticals Ltd. Fellow subsidiary Sale of goods or services 50.00 Approved 0.00 11.80 13.80
130 Akumentis Healthcare Limited Plenteous Pharmaceuticals Ltd. Fellow subsidiary Any other transaction Royalty Income 100.00 Approved 12.80 0.00 0.00
131 Akumentis Healthcare Limited Pure & Cure Healthcare Pvt. Ltd. Fellow subsidiary Purchase of goods or services 5,000.00 Approved 1,287.00 446.60 236.10
132 Akumentis Healthcare Limited Pure & Cure Healthcare Pvt. Ltd. Fellow subsidiary Any other transaction Expenses incurred 1,000.00 Approved 1.90 0.00 0.00
133 Akumentis Healthcare Limited Unosource Pharma Ltd. Fellow subsidiary Any other transaction Loan given 1,000.00 Approved 0.00 1,910.00 970.00 Loan 7.2500 Upto Jan-2028 Unsecured Business purpose
134 Akumentis Healthcare Limited Unosource Pharma Ltd. Fellow subsidiary Any other transaction Interest income 120.40 Approved 64.30 10.90 7.00
135 Akumentis Healthcare Limited Unosource Pharma Ltd. Fellow subsidiary Any other transaction Loan repaid 2,000.00 Approved 940.00 0.00 0.00
136 Akumentis Healthcare Limited Upadhrish Reserchem LLP Fellow subsidiary Purchase of goods or services 50.00 Approved 0.00 6.10 0.00
137 Akumentis Healthcare Limited Upadhrish Reserchem LLP Fellow subsidiary Any other transaction Expenses incurred 200.00 Approved 18.20 0.00 0.00
138 Akumentis Healthcare Limited Medibox Pharma Pvt. Ltd. Fellow subsidiary Any other transaction Loan repaid 500.00 Approved 115.00 0.00 0.00 Loan 7.2500 Upto Jan-2028 Unsecured Business purpose
139 Akumentis Healthcare Limited Medibox Pharma Pvt. Ltd. Fellow subsidiary Any other transaction Interest income 239.40 Approved 97.30 15.40 13.90
140 Akumentis Healthcare Limited Akums Health and Education Society Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction CSR Contribution 400.00 Approved 67.90 0.00 0.00
141 Akumentis Healthcare Limited Akums Foundation Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction CSR Contribution 400.00 Approved 67.90 0.00 0.00
142 Malik Lifesciences Pvt. Ltd. Akums Healthcare Ltd. Fellow Subsidiary Purchase of goods or services Exempt under regulation 23(5) 375.20 52.10 203.70
143 Malik Lifesciences Pvt. Ltd. Akums Healthcare Ltd. Fellow subsidiary Any other transaction Expenses incurred Exempt under regulation 23(5) 0.80 0.00 0.00
144 Malik Lifesciences Pvt. Ltd. Akums Healthcare Ltd. Fellow subsidiary Any other transaction Purchase of Property, Plant and Equipment Exempt under regulation 23(5) 0.90 0.00 0.00
145 Malik Lifesciences Pvt. Ltd. Akums Healthcare Ltd. Fellow subsidiary Any other transaction Job Work Charges Exempt under regulation 23(5) 585.10 0.00 0.00
146 Malik Lifesciences Pvt. Ltd. Akums Healthcare Ltd. Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 201.90 16.20 46.90
147 Malik Lifesciences Pvt. Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Expenses paid by other Group Company 500.00 Approved 12.30 0.00 0.00
148 Malik Lifesciences Pvt. Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Purchase of goods or services 500.00 Approved 7.40 0.20 3.60
149 Malik Lifesciences Pvt. Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Rent Paid 500.00 Approved 44.20 0.00 0.00
150 Malik Lifesciences Pvt. Ltd. Akums Health and Education Society Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction CSR Contribution 200.00 Approved 16.80 0.00 0.00
151 Malik Lifesciences Pvt. Ltd. Akums Foundation Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction CSR Contribution 200.00 Approved 16.80 0.00 0.00
152 Malik Lifesciences Pvt. Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Purchase of goods or services Exempt under regulation 23(5) 2,874.50 2,603.80 279.00
153 Malik Lifesciences Pvt. Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Any other transaction Sale of Property, Plant and Equipment Exempt under regulation 23(5) 0.10 0.00 0.00
154 Malik Lifesciences Pvt. Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 689.50 0.20 439.50
155 Malik Lifesciences Pvt. Ltd. Medibox Pharma Pvt. Ltd. Fellow subsidiary Any other transaction Service Income Exempt under regulation 23(5) 0.00 0.00 0.00
156 Malik Lifesciences Pvt. Ltd. Medibox Pharma Pvt. Ltd. Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 54.70 56.20 38.50
157 Malik Lifesciences Pvt. Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 228.90 195.90 196.30
158 Malik Lifesciences Pvt. Ltd. Plenteous Pharmaceuticals Ltd. Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 101.60 187.40 83.00
159 Malik Lifesciences Pvt. Ltd. Plenteous Pharmaceuticals Ltd. Fellow Subsidiary Any other transaction Service Income Exempt under regulation 23(5) 0.00 0.00 0.00
160 Malik Lifesciences Pvt. Ltd. Qualymed Pharma Pvt. Ltd. Fellow Subsidiary Purchase of goods or services Exempt under regulation 23(5) 8.70 0.00 0.50
161 Malik Lifesciences Pvt. Ltd. Unosource Pharma Ltd. Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 841.40 510.00 379.30
162 Malik Lifesciences Pvt. Ltd. Unosource Pharma Ltd. Fellow Subsidiary Any other transaction Service Income Exempt under regulation 23(5) 0.00 0.00 0.00
163 Malik Lifesciences Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Consumption of stores and spare parts Exempt under regulation 23(5) 90.70 0.00 0.00
164 Malik Lifesciences Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Repairs and maintenance- Plant and machinery Exempt under regulation 23(5) 31.40 0.00 0.00
165 Malik Lifesciences Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Expenses incurred Exempt under regulation 23(5) 0.00 0.00 0.00
166 Malik Lifesciences Pvt. Ltd. Upadhrish Reserchem LLP Fellow subsidiary Any other transaction Purchase of Property, Plant and Equipment Exempt under regulation 23(5) 0.80 0.00 0.00
167 Malik Lifesciences Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Purchase of goods or services Exempt under regulation 23(5) 26.50 (1.00) 17.60
168 Malik Lifesciences Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Sale of Property, Plant and Equipment Exempt under regulation 23(5) 80.30 0.00 0.00
169 Malik Lifesciences Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 0.00 4.30 86.00
170 Akums Healthcare Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Purchase of goods or services 500.00 Approved 16.80 3.10 0.50
171 Akums Healthcare Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Rent Paid 500.00 Approved 1.20 0.00 0.00
172 Akums Healthcare Ltd. Medibox Pharma Pvt. Ltd. Fellow subsidiary Purchase of goods or services Exempt under regulation 23(5) 0.30 0.00 0.00
173 Akums Healthcare Ltd. Medibox Pharma Pvt. Ltd. Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 0.00 4.60 0.00
174 Akums Healthcare Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 17.10 6.60 17.90
175 Akums Healthcare Ltd. Plenteous Pharmaceuticals Ltd. Fellow subsidiary Purchase of goods or services Exempt under regulation 23(5) 0.50 0.00 0.00
176 Akums Healthcare Ltd. Plenteous Pharmaceuticals Ltd. Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 27.80 7.30 26.80
177 Akums Healthcare Ltd. Qualymed Pharma Pvt. Ltd. Fellow Subsidiary Purchase of goods or services Exempt under regulation 23(5) 6.30 1.30 3.10
178 Akums Healthcare Ltd. Unosource Pharma Ltd. Fellow subsidiary Sale of goods or services Exempt under regulation 23(5) 23.40 0.00 18.40
179 Akums Healthcare Ltd. Unosource Pharma Ltd. Fellow subsidiary Any other transaction Service Income Exempt under regulation 23(5) 9.90 0.00 0.00
180 Akums Healthcare Ltd. Unosource Pharma Ltd. Fellow Subsidiary Any other transaction Expense incurred on behalf of Company Exempt under regulation 23(5) 0.00 0.00 0.00
181 Akums Healthcare Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Consumption of stores and spare parts Exempt under regulation 23(5) 46.40 0.00 0.00
182 Akums Healthcare Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Repairs and maintenance- Plant and machinery Exempt under regulation 23(5) 30.90 0.00 0.00
183 Akums Healthcare Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Purchase of goods or services Exempt under regulation 23(5) 31.50 7.60 15.60
184 Akums Healthcare Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Sale of Property, Plant and Equipment Exempt under regulation 23(5) 1.00 0.00 0.00
185 Akums Healthcare Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 0.00 1.90 1.20
186 Maxcure Nutravedics Ltd. Akums Healthcare Ltd. Fellow Subsidiary Purchase of goods or services Exempt under regulation 23(5) 0.30 9.40 0.00
187 Maxcure Nutravedics Ltd. Akums Healthcare Ltd. Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 86.10 37.50 19.70
188 Maxcure Nutravedics Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Expenses paid by other Group Company 500.00 Approved 6.10 0.00 0.00
189 Maxcure Nutravedics Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Purchase of goods or services 500.00 Approved 22.10 3.90 2.00
190 Maxcure Nutravedics Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Sale of goods or services 500.00 Approved 0.20 0.00 0.20
191 Maxcure Nutravedics Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Rent Paid 500.00 Approved 21.80 0.00 0.00
192 Maxcure Nutravedics Ltd. Akums Health and Education Society Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction CSR Contribution 200.00 Approved 23.60 0.00 0.00
193 Maxcure Nutravedics Ltd. Akums Foundation Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction CSR Contribution 200.00 Approved 23.60 0.00 0.00
194 Maxcure Nutravedics Ltd. Akums Foundation Entities where significant influence is exercised by KMP and/or their relatives of holding company Sale of goods or services 200.00 Approved 0.50 0.00 0.60
195 Maxcure Nutravedics Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Purchase of goods or services Exempt under regulation 23(5) 0.00 (0.20) 0.00
196 Maxcure Nutravedics Ltd. Plenteous Pharmaceuticals Ltd. Fellow subsidiary Sale of goods or services Exempt under regulation 23(5) 5.70 0.00 6.00
197 Maxcure Nutravedics Ltd. Qualymed Pharma Pvt. Ltd. Fellow Subsidiary Purchase of goods or services Exempt under regulation 23(5) 3.00 2.90 0.10
198 Maxcure Nutravedics Ltd. Unosource Pharma Ltd. Fellow Subsidiary Any other transaction Purchase of RODTEP scrips Exempt under regulation 23(5) 35.70 0.00 3.50
199 Maxcure Nutravedics Ltd. Unosource Pharma Ltd. Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 57.50 39.00 48.10
200 Maxcure Nutravedics Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Consumption of stores and spare parts Exempt under regulation 23(5) 144.40 0.00 0.00
201 Maxcure Nutravedics Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Repairs and maintenance- Plant and machinery Exempt under regulation 23(5) 9.30 0.00 0.00
202 Maxcure Nutravedics Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Expenses incurred Exempt under regulation 23(5) 2.60 0.00 0.00
203 Maxcure Nutravedics Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Purchase of Property, Plant and Equipment Exempt under regulation 23(5) 0.80 0.00 0.00
204 Maxcure Nutravedics Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Purchase of goods or services Exempt under regulation 23(5) 113.80 0.10 32.30
205 Maxcure Nutravedics Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 149.30 147.20 147.70
206 Medibox Pharma Pvt. Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Any other transaction Expense incurred on behalf of Company Exempt under regulation 23(5) 0.00 0.00 0.00
207 Medibox Pharma Pvt. Ltd. Plenteous Pharmaceuticals Ltd. Fellow Subsidiary Any other transaction Expense incurred on behalf of Company Exempt under regulation 23(5) 0.00 0.00 0.00
208 Nicholas Healthcare Ltd. May and Baker Pharmaceuticals Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Sale of goods or services 500.00 Approved 5.10 0.00 0.00
209 Nicholas Healthcare Ltd. Plenteous Pharmaceuticals Ltd. Fellow Subsidiary Any other transaction Rent Received Exempt under regulation 23(5) 5.40 0.00 0.00
210 Nicholas Healthcare Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Expenses incurred Exempt under regulation 23(5) 0.90 0.00 0.00
211 Plenteous Pharmaceuticals Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Expenses incurred Exempt under regulation 23(5) 1.50 0.00 0.00
212 Pure & Cure Healthcare Pvt. Ltd. Akums Healthcare Ltd. Fellow Subsidiary Any other transaction Expense incurred on behalf of Company Exempt under regulation 23(5) 0.10 0.00 0.00
213 Pure & Cure Healthcare Pvt. Ltd. Akums Healthcare Ltd. Fellow subsidiary Any other transaction Expenses incurred Exempt under regulation 23(5) 0.60 0.00 0.00
214 Pure & Cure Healthcare Pvt. Ltd. Akums Healthcare Ltd. Fellow subsidiary Any other transaction Service Income Exempt under regulation 23(5) 0.10 0.00 0.00
215 Pure & Cure Healthcare Pvt. Ltd. Akums Healthcare Ltd. Fellow Subsidiary Purchase of goods or services Exempt under regulation 23(5) 9.10 1.40 3.50
216 Pure & Cure Healthcare Pvt. Ltd. Akums Healthcare Ltd. Fellow Subsidiary Any other transaction Sale of Property, Plant and Equipment Exempt under regulation 23(5) 0.30 0.00 0.00
217 Pure & Cure Healthcare Pvt. Ltd. Akums Healthcare Ltd. Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 4.30 1.60 2.40
218 Pure & Cure Healthcare Pvt. Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Expenses paid by other Group Company 72.60 Approved 36.80 0.00 0.00
219 Pure & Cure Healthcare Pvt. Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Purchase of goods or services 297.30 Approved 64.70 8.20 13.80
220 Pure & Cure Healthcare Pvt. Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Rent Paid 330.50 Approved 132.20 0.00 0.00
221 Pure & Cure Healthcare Pvt. Ltd. Amazing Research Laboratories Ltd Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Rent Received 1,000.00 Approved 0.10 0.00 0.00
222 Pure & Cure Healthcare Pvt. Ltd. May and Baker Pharmaceuticals Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Purchase of Property, Plant and Equipment 1,000.00 Approved 0.10 0.00 0.10
223 Pure & Cure Healthcare Pvt. Ltd. May and Baker Pharmaceuticals Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Rent Received 1,000.00 Approved 0.10 0.00 0.00
224 Pure & Cure Healthcare Pvt. Ltd. Malik Lifesciences Pvt. Ltd. Fellow subsidiary Any other transaction Expenses incurred Exempt under regulation 23(5) 4.50 0.00 0.00
225 Pure & Cure Healthcare Pvt. Ltd. Malik Lifesciences Pvt. Ltd. Fellow Subsidiary Any other transaction Purchase of Property, Plant and Equipment Exempt under regulation 23(5) 80.00 0.00 0.00
226 Pure & Cure Healthcare Pvt. Ltd. Malik Lifesciences Pvt. Ltd. Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 8.10 0.70 0.60
227 Pure & Cure Healthcare Pvt. Ltd. Malik Lifesciences Pvt. Ltd. Fellow Subsidiary Any other transaction Sale of Property, Plant and Equipment Exempt under regulation 23(5) 3.10 0.00 0.00
228 Pure & Cure Healthcare Pvt. Ltd. Malik Lifesciences Pvt. Ltd. Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 1,306.50 171.60 727.70
229 Pure & Cure Healthcare Pvt. Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Any other transaction Expenses incurred Exempt under regulation 23(5) 0.60 0.00 0.00
230 Pure & Cure Healthcare Pvt. Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Any other transaction Purchase of Property, Plant and Equipment Exempt under regulation 23(5) 0.10 0.00 0.00
231 Pure & Cure Healthcare Pvt. Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Purchase of goods or services Exempt under regulation 23(5) 6,488.30 1,995.70 1,743.50
232 Pure & Cure Healthcare Pvt. Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Any other transaction Sale of Property, Plant and Equipment Exempt under regulation 23(5) 5.50 0.00 0.00
233 Pure & Cure Healthcare Pvt. Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 560.70 103.00 417.80
234 Pure & Cure Healthcare Pvt. Ltd. Medibox Pharma Pvt. Ltd. Fellow subsidiary Any other transaction Expenses incurred Exempt under regulation 23(5) 0.10 0.00 0.00
235 Pure & Cure Healthcare Pvt. Ltd. Medibox Pharma Pvt. Ltd. Fellow subsidiary Any other transaction Rent Received Exempt under regulation 23(5) 0.20 0.00 0.00
236 Pure & Cure Healthcare Pvt. Ltd. Medibox Pharma Pvt. Ltd. Fellow subsidiary Any other transaction Purchase of Property, Plant and Equipment Exempt under regulation 23(5) 0.70 0.00 0.00
237 Pure & Cure Healthcare Pvt. Ltd. Medibox Pharma Pvt. Ltd. Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 110.80 62.20 20.50
238 Pure & Cure Healthcare Pvt. Ltd. Medibox Pharma Pvt. Ltd. Fellow Subsidiary Any other transaction Service Income Exempt under regulation 23(5) 0.20 0.00 0.00
239 Pure & Cure Healthcare Pvt. Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Any other transaction Expense incurred on behalf of Company Exempt under regulation 23(5) 0.00 0.00 0.00
240 Pure & Cure Healthcare Pvt. Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Any other transaction Purchase of Property, Plant and Equipment Exempt under regulation 23(5) 2.50 0.00 0.00
241 Pure & Cure Healthcare Pvt. Ltd. Nicholas Healthcare Ltd. Fellow subsidiary Any other transaction Expenses paid by other Group Company Exempt under regulation 23(5) 0.00 0.00 0.00
242 Pure & Cure Healthcare Pvt. Ltd. Nicholas Healthcare Ltd. Fellow subsidiary Any other transaction Expenses incurred Exempt under regulation 23(5) 0.80 0.00 0.00
243 Pure & Cure Healthcare Pvt. Ltd. Nicholas Healthcare Ltd. Fellow subsidiary Any other transaction Rent Received Exempt under regulation 23(5) 0.20 0.00 0.00
244 Pure & Cure Healthcare Pvt. Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Purchase of goods or services Exempt under regulation 23(5) 0.00 0.00 0.10
245 Pure & Cure Healthcare Pvt. Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 444.00 711.00 422.50
246 Pure & Cure Healthcare Pvt. Ltd. Plenteous Pharmaceuticals Ltd. Fellow subsidiary Any other transaction Expenses incurred Exempt under regulation 23(5) 0.10 0.00 0.00
247 Pure & Cure Healthcare Pvt. Ltd. Plenteous Pharmaceuticals Ltd. Fellow subsidiary Any other transaction Rent Received Exempt under regulation 23(5) 0.20 0.00 0.00
248 Pure & Cure Healthcare Pvt. Ltd. Plenteous Pharmaceuticals Ltd. Fellow subsidiary Any other transaction Purchase of Property, Plant and Equipment Exempt under regulation 23(5) 0.80 0.00 0.00
249 Pure & Cure Healthcare Pvt. Ltd. Plenteous Pharmaceuticals Ltd. Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 82.30 249.10 76.80
250 Pure & Cure Healthcare Pvt. Ltd. Plenteous Pharmaceuticals Ltd. Fellow Subsidiary Any other transaction Service Income Exempt under regulation 23(5) 0.10 0.00 0.00
251 Pure & Cure Healthcare Pvt. Ltd. Qualymed Pharma Pvt. Ltd. Fellow Subsidiary Purchase of goods or services Exempt under regulation 23(5) 266.60 53.80 113.20
252 Pure & Cure Healthcare Pvt. Ltd. Qualymed Pharma Pvt. Ltd. Fellow subsidiary Any other transaction Expenses incurred Exempt under regulation 23(5) 0.10 0.00 0.00
253 Pure & Cure Healthcare Pvt. Ltd. Qualymed Pharma Pvt. Ltd. Fellow subsidiary Any other transaction Purchase of Property, Plant and Equipment Exempt under regulation 23(5) 0.40 0.00 0.00
254 Pure & Cure Healthcare Pvt. Ltd. Qualymed Pharma Pvt. Ltd. Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 0.50 0.00 0.50
255 Pure & Cure Healthcare Pvt. Ltd. Unosource Pharma Ltd. Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 170.10 0.00 67.60
256 Pure & Cure Healthcare Pvt. Ltd. Unosource Pharma Ltd. Fellow Subsidiary Any other transaction Service Income Exempt under regulation 23(5) 0.00 0.00 0.00
257 Pure & Cure Healthcare Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Consumption of stores and spare parts Exempt under regulation 23(5) 447.70 0.00 0.00
258 Pure & Cure Healthcare Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Repairs and maintenance- Plant and machinery Exempt under regulation 23(5) 72.10 0.00 0.00
259 Pure & Cure Healthcare Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Expenses incurred Exempt under regulation 23(5) 1.70 0.00 0.00
260 Pure & Cure Healthcare Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Purchase of Property, Plant and Equipment Exempt under regulation 23(5) 129.10 0.00 0.00
261 Pure & Cure Healthcare Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Purchase of goods or services Exempt under regulation 23(5) 521.50 21.00 99.30
262 Pure & Cure Healthcare Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Sale of Property, Plant and Equipment Exempt under regulation 23(5) 46.00 0.00 0.00
263 Pure & Cure Healthcare Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 14.00 244.50 69.90
264 Pure & Cure Healthcare Pvt. Ltd. Sarvagunaushdhi Pvt. Ltd. Fellow subsidiary Any other transaction Rent Received Exempt under regulation 23(5) 0.30 0.00 0.00
265 Pure & Cure Healthcare Pvt. Ltd. Sarvagunaushdhi Pvt. Ltd. Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 0.00 938.20 845.10
266 Qualymed Pharma Pvt. Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Sale of goods or services 500.00 Approved 1.60 0.00 0.00
267 Qualymed Pharma Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Purchase of goods or services Exempt under regulation 23(5) 0.00 0.00 0.50
268 Qualymed Pharma Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Sale of goods or services Exempt under regulation 23(5) 0.00 0.60 0.00
269 Qualymed Pharma Pvt. Ltd. Upadhrish Reserchem LLP Fellow subsidiary Any other transaction Purchase of Property, Plant and Equipment Exempt under regulation 23(5) 0.40 0.00 0.00
270 Qualymed Pharma Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Expenses incurred Exempt under regulation 23(5) 0.40 0.00 0.00
271 Unosource Pharma Ltd. Akums Health and Education Society Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction CSR Contribution 200.00 Approved 23.10 0.00 0.00
272 Unosource Pharma Ltd. Akums Foundation Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction CSR Contribution 200.00 Approved 23.10 0.00 0.00
273 Unosource Pharma Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Any other transaction Purchase of Property, Plant and Equipment Exempt under regulation 23(5) 0.10 0.00 0.00
274 Unosource Pharma Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Expense incurred on behalf of Company Exempt under regulation 23(5) 0.30 0.00 0.00
275 Upadhrish Reserchem LLP Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Purchase of goods or services 500.00 Approved 0.00 0.00 0.00
276 Malik Lifesciences Pvt. Ltd. Mr. Sandeep Jain KMP in holding company Any other transaction Rent Paid 10.00 Approved 1.80 0.00 0.00
277 Maxcure Nutravedics Ltd. Mr. Sanjeev Jain KMP in holding company Any other transaction Rent Paid 10.00 Approved 0.80 0.00 0.00
278 Pure & Cure Healthcare Pvt. Ltd. Mr. Sandeep Jain KMP in holding company Any other transaction Rent Paid 10.00 Approved 0.50 0.00 0.00
279 Pure & Cure Healthcare Pvt. Ltd. Ms. Lata Jain Relatives of KMP in holding Company Remuneration 10.00 Approved 0.00 2.80 0.00
280 Pure & Cure Healthcare Pvt. Ltd. Ms. Archana Jain Relatives of KMP in holding Company Any other transaction Rent Paid 10.00 Approved 0.60 0.00 0.00
281 Maxcure Nutravedics Ltd. Ms. Archana Jain Relatives of KMP in holding Company Remuneration 10.00 Approved 0.00 3.30 0.00
282 Akumentis Healthcare Limited Mr. Kanishk Jain Director Remuneration 70.00 Approved 32.80 5.60 4.40
283 Akumentis Healthcare Limited Mr. Sanjeev Jain KMP in holding company Any other transaction Security deposit given 120.00 Approved 0.00 50.00 50.00
284 Akumentis Healthcare Limited Mr. Sandeep Jain KMP in holding company Any other transaction Security deposit given 120.00 Approved 0.00 50.00 50.00
285 Unosource Pharma Ltd. Mr. Sanjeev Jain KMP in holding company Any other transaction Rent Paid 120.00 Approved 50.50 0.00 0.00
286 Unosource Pharma Ltd. Mr. Sandeep Jain KMP in holding company Any other transaction Rent Paid 120.00 Approved 51.10 0.00 0.00
287 Medibox Pharma Pvt. Ltd. Mr. Sanjeev Jain KMP in holding company Any other transaction Rent Paid 1.00 Approved 0.00 0.00 0.00
288 Nicholas Healthcare Ltd. Mr. Sandeep Jain KMP in holding company Any other transaction Rent Paid 1.00 Approved 0.00 0.00 0.00
289 Sarvagunaushdhi Pvt. Ltd. Mr. Sanjeev Jain KMP in holding company Any other transaction Rent Paid 1.00 Approved 0.00 0.00 0.00
290 Plenteous Pharmaceuticals Ltd. Mr. Sanjeev Jain KMP in holding company Any other transaction Rent Paid 1.50 Approved 0.60 0.00 0.00
291 Akumentis Healthcare Limited Mr. Sanjeev Jain KMP in holding company Any other transaction Rent Paid 110.00 Approved 44.40 0.00 0.00
292 Akumentis Healthcare Limited Mr. Sandeep Jain KMP in holding company Any other transaction Rent Paid 110.00 Approved 44.40 0.00 0.00
293 Akumentis Healthcare Limited Ms. Lata Jain Relatives of KMP in holding Company Any other transaction Rent Paid 3.00 Approved 1.20 0.00 0.00
294 Akums Healthcare Ltd. Mr. Sanjeev Jain KMP in holding company Any other transaction Rent Paid 1.00 Approved 0.40 0.00 0.00
295 Qualymed Pharma Pvt. Ltd. Mr. Sandeep Jain KMP in holding company Any other transaction Rent Paid 2.50 Approved 1.00 0.00 0.00
296 Upadhrish Reserchem LLP Mr. Sandeep Jain KMP in holding company Any other transaction Rent Paid 3.50 Approved 1.40 0.00 0.00
Total value of transaction during the reporting period 1,40,983.90